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Abstract 35 
Recently there has been a considerable rise in the frequency of metabolic diseases, such as obesity, 36 
due to changes in lifestyle and resultant imbalances between energy intake and expenditure. Whey 37 
proteins are considered as potentially important components of a dietary solution to the obesity 38 
problem. However, the roles of individual whey proteins in energy balance remain poorly 39 
understood. This study investigated the effects of a high fat diet (HFD) containing alpha-40 
lactalbumin (LAB), a specific whey protein, or the non-whey protein casein (CAS), on energy 41 
balance, nutrient transporters expression, and enteric microbial populations. C57BL/6J mice (n = 8) 42 
were given a HFD containing either 20% CAS or LAB as protein sources or a low-fat diet (LFD) 43 
containing CAS for 10 weeks. HFD-LAB fed mice showed a significant increase in cumulative 44 
energy intake (P=0.043), without differences in body weight, energy expenditure, locomotor 45 
activity, respiratory exchange ratio or subcutaneous and epididymal adipose tissue weight. HFD-46 
LAB intake led to a decrease in the expression of glucose transporter glut2 in the ileum (P=0.05) 47 
and in the fatty acid transporter cd36 (P<0.001) in both ileum and jejunum. This suggests a 48 
reduction of absorption efficiency within the small intestine in the HFD-LAB group. DNA from 49 
faecal samples was used for 16S rRNA-based assessment of intestinal microbiota populations; the 50 
genera Lactobacillus, Parabacteroides and Bifidobacterium were present in significantly higher 51 
proportions in the HFD-LAB group. These data indicate a possible functional relationship between 52 
gut microbiota, intestinal nutrient transporters and energy balance, with no impact on weight gain. 53 
Introduction 54 
Obesity has emerged as one of the most prevalent global health problems over the last 30 years 55 
because of its association with comorbidities such as chronic inflammations, type II diabetes, 56 
cardiovascular disorders and certain types of cancer
(1)
. Whilst the aetiology of obesity is 57 
multifactorial, there is a growing recognition that high energy density diets (containing high levels 58 
of fat and sugar) are major contributors to long-term imbalance between energy intake and energy 59 
expenditure
(2)
, with comparable effects seen in rodents including mice such as the C57BL/6J strain. 60 
Indeed, energy dense diets increase intestinal energy absorption and fat storage in adipose tissue
(3)
. 61 
Additionally, these diets impair the hypothalamic regulation of hormones involved in the control of 62 
energy balance
(4)
. Thus, one approach to reducing weight gain or causing weight loss would be to 63 
devise interventions that affect the cross-talk between the gut, adipose tissue and the hypothalamic 64 
mechanisms regulating energy balance. 65 
Nutrient digestion and absorption provides the necessary energy for the survival of living organisms 66 
and the gastrointestinal (GI) tract has evolved to optimise these processes
(5)
. In particular, nutrient 67 
absorption takes place in the duodenum, jejunum and ileum, through paracellular movements or by 68 
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uptake through specific nutrient transporters, which are able to transport fats (e.g., Fatty Acid 69 
Transporter, FATP4; Cluster Differentiation 36, CD36), sugars (i.e. Glucose Transporter 2, 70 
GLUT2; Sodium-Glucose transporter Protein 1, SGLT1) and amino acids (i.e. L-type Amino acid 71 
Transporter 4, LAT4; neural amino acid transporter 1, B
0
AT1) into the blood stream
(6)
. 72 
The complexity of nutrient absorption is further highlighted by the network of diverse intrinsic and 73 
extrinsic factors regulating this process. With regard to intrinsic factors, it is notable that deficiency 74 
of the anoretic hormone leptin in mice
(6)
 increases energy ingestion leading to a greater adiposity 75 
and weight gain, coupled with associated hypothalamic-neuropeptide changes and chronic intestinal 76 
inflammation
(7)
. Similarly, targeted deletion of the gene encoding GLUT2, a key intestinal glucose 77 
transporter, also increases energy intake
(8)
.  78 
Of the extrinsic factors, the gut microbiota plays a key role in harvesting energy from ingested food 79 
and providing it for host metabolism
(9; 10; 11; 12)
. Hence, germ free mice are protected against obesity 80 
despite consuming more calories than control mice, but this phenotype is reverted after faecal 81 
microbiota transplantation from conventionally raised mice
(13)
. Using gnotobiotic mice fed a high-82 
fat or low-fat diet (HFD and LFD, respectively), a role has been suggested for Clostridium 83 
ramosum in the upregulation of body fat deposition promoting factors
(14)
. These data, coupled with 84 
the observed impact of gut microbiota on brain formation, including hypothalamic micro-85 
structures
(15)
, provide novel avenues for modulating the activity of the intestine, adipose tissue and 86 
hypothalamus, involving microorganisms. 87 
Αlpha-lactalbumin (LAB) is a globular protein well known as a source of peptides having beneficial 88 
properties such as antioxidant bioactivity and immune modulation ability
(16)
. It constitutes around 89 
25% of the bovine milk whey proteins
(16)
. Whey can be extracted during the manufacture of cheese 90 
and comprises also other protein types, varying in abundances, including β-lactoglobulin (~ 65%), 91 
bovine serum albumin (BSA, ~8%), lactoperoxidase (0.25-0.5%), lactoferrin (Lf, ~1%) as well as 92 
other minor proteins such as immunoglobulins (<1%)
(17)
. Recently, whey proteins have been 93 
considered as a potential dietary solution to obesity in light of the discovery that these proteins, as 94 
an isolate (WPI) or concentrate (WPC), acutely increases the production of hormones that are 95 
involved in satiety in both humans and rodents
(18; 19)
. Moreover, intake of whey proteins in humans 96 
reduces fat absorption
(20)
. This effect might be attributed to an altered composition of the gut 97 
microbiota involved in energy harvest, since other studies have shown that dietary whey proteins 98 
can influence the composition of the gut microbiota
(21; 22; 23; 24)
.  Indeed, we showed that WPI 99 
reduced the proportion of Firmicutes in the mouse gut microbiome
(22)
, and this was accompanied by 100 
a reduction in the expression of intestinal nutrient transporters, specifically glut2 and fatp4. . In 101 
addition, we showed that WPI reduced epididymal adipose tissue (eWAT) weight and overall body 102 
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weight gain. Consistent with changes in the gut, WPI increased energy intake, which was reflected 103 
in the altered hypothalamic gene expression of neuropeptides, namely proopiomelanocortin (pomc), 104 
neuropeptide Y (npy) and ghrelin
(22)
.  105 
While these data suggest a modulatory effect of WPI on the gut microbiome, hypothalamus and 106 
adipose tissue, it was not clear if the changes in energy intake were driven directly from the 107 
gut/hypothalamus axis or were secondary to the changes in adiposity. Indeed, previously it was 108 
shown that specific whey proteins, such as BSA and Lf, influenced in a different way body weight, 109 
energy intake and plasma leptin level
(25; 26)
. 110 
Given that LAB has been shown to affect the energy balance but the underlying mechanism is still 111 
unclear
(27; 28)
, in the current study we sought to further investigate the link established previously 112 
between gut-hypothalamic-adipose control of energy balance using LAB as the main protein source. 113 
The protein was given in a physiological amount (i.e. 20% calories) during HFD-induced weight 114 
gain phase in the C57BL/6J strain of mice, which was used as the model for humans. LAB was 115 
introduced early in development (5 weeks of age), given WPI specificity to influence weight gain 116 
during this period
(29)
. As the control, we fed mice a LFD or HFD containing the same physiological 117 
amount of a non-whey milk protein, casein. 118 
 119 
 120 
 121 
Material and Methods 122 
Experimental strategy 123 
The in vivo experiments were approved by the University College Cork Animal Experimentation 124 
Ethics Committee (2011/005) and were licenced under the European Directive 2010/63/EU. 125 
Twenty-four C57BL/6J three week old male specific pathogen free mice were purchased 126 
commercially (Harlan; UK) and were singly housed in each cage with enrichment (Litaspen 8/20 127 
and alpha-dry Plus bedding; LBS-biotech, UK) on a 12 h light/dark cycle with humidity maintained 128 
at 45-60% and temperature between 19-22°C. The mice had ad libitum access to food and water 129 
throughout the study unless otherwise stated. The health of the animals and the environment 130 
parameters were checked and recorded daily. No adverse effects were observed by the dietary 131 
interventions or procedures detailed below. The mice were provided with a diet containing 10% 132 
(low) fat and 20% casein (LFD-CAS; #D12450Bi; Research Diets, USA) (all % values by energy) 133 
during the initial 2 week acclimatisation period, and then weight matched mice were switched to a 134 
45% (high) fat diet containing either 20% casein (HFD-CAS; #D12451i) or alpha-lactalbumin 135 
(HFD-LAB; #D13081701i) (n=8 per group). The controls continued to receive LFD-CAS (n=8). 136 
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The diets were OpenSource and were made by Research Diets, USA, with LAB sourced from 137 
Sigma, USA (diets composition details, Table S1). Body weight as well as food intake were 138 
measured weekly. The latter was converted to gross energy intake using the dietary energy density 139 
of the diets (HFD=19.79 KJ/g and LFD=16.11 KJ/g; Research Diets, USA). 140 
During weeks 8 and 9, mice were placed in TSE Phenomaster cages (Germany) for 3 days to 141 
measure metabolic parameters, specifically, oxygen consumption (ml/h, VO2), carbon dioxide 142 
production (ml/h, VCO2), respiratory exchange ratio (VCO2/VO2, RER) and locomotor activity 143 
(X, Y and Z planes). The data were collected in the final 24h of the housing period as detailed 144 
previously(30). 145 
At week 10, mice were fasted for 10-12h commencing at 22.00 in the dark phase, then 146 
anaesthetized (100mg/Kg Ketamine and 10 mg/Kg Xylazine) and blood samples were collected. 147 
Mice were sacrificed by cervical dislocation and tissues were collected and samples were stored at -148 
80˚C for subsequent analysis. The length of the small intestine and the weight of all the tissues were 149 
recorded on fresh tissues before snap freezing them. 150 
 151 
DNA Sequencing 152 
Faecal samples were collected directly from the colon, homogenized and processed using 153 
mechanical and chemical lysis. The 16S rRNA gene (V3-V4 region) was amplified with Universal 154 
primers (PCR1 Forward and Reverse primer as to the Illumina 16S Metagenomic Sequencing 155 
Protocol) that facilitated sequencing on the Illumina MiSeq platform (2x250bp paired-end reads; V3 156 
sequencing chemistry). The fastq files were filtered on the basis of quality (removal of low quality 157 
nucleotides at the 3' end) and length (removal of sequences with less than 200nt) with prinseq
(31)
, 158 
and paired reads with a minimum overlap of 20 bp were joined using Fastq-join
(32)
. 159 
Sequences were clustered (97% identity) to obtain Operative Taxonomic Units (OTUs) using 160 
closed-reference usearch v7.0 algorithm
(33)
 and chimeric OTUs were removed through use of the 161 
gold database. The taxonomic assignment of OTUs was obtained using the Ribosomal database 162 
project (RDP)
(34)
. Alpha and beta-diversity was determined using QIIME
(35)
, and additional 163 
analyses were performed with the R package phyloseq
(36)
. 164 
To identify chow-associated microbes, total DNA was extracted from ~ 10 g of chow containing 165 
20% fat and 20% casein (LFD-CAS; #D17052702; Research Diets, USA), and ~ 10 g of chow 166 
containing 40% fat and 20% casein (HFD-CAS; #D17052705; Research Diets, USA) using the 167 
Gene All Extragene SoilSV kit (GeneAll). The Qubit high-sensitivity DNA assay (Bio-Sciences, 168 
Dublin, Ireland) was used for accurate quantification of the total DNA. Whole-metagenome shotgun 169 
libraries preparation was performed following the Nextera XT DNA library preparation guide from 170 
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Illumina
(37)
 and sequencing was performed using the Illumina NextSeq 500 with a v2 NextSeq 171 
500/550 high-output reagent kit (300 cycles). 172 
The raw shotgun metagenomic sequences were filtered on the basis of quality (removal of low 173 
quality nucleotides at the 3' end and application of sliding window trimming, cutting once the 174 
average quality within the window falls below a treshold quality of 20 bp) and length (removal of 175 
sequences of less than 200nt) with prinseq
(31)
. The filtered sequences were then converted to bam 176 
files using SAMtools
(38)
, and duplicate reads were subsequently removed using Picard Tools 177 
(https://github.com/broadinstitute/picard). The quality of the sequences was tested using SAMtools 178 
in combination with Picard Tools, removing the low quality sequences. Taxonimic analysis was 179 
performed using Kaiju
(39)
. 180 
Gene expression 181 
The small intestine samples, stored at -80˚C, were initially immersed in a RNAlater-Ice frozen 182 
tissue transition solution and stored at -20˚C according to the instructions of the manufacturer 183 
(Ambion). This step allows untangling of the intestine while preserving the integrity of the RNA so 184 
that tissue samples, corresponding to the ileum (1 cm from the distal end of the small intestine) and 185 
jejunum (the central part of the small intestine), could be cut. 186 
Total RNA was extracted from the intestinal samples and hypothalamic blocks using RNeasy 187 
Minikit and QIAshredder columns (Qiagen), and from epididymal adipose tissue (eWAT) and 188 
subcutaneous adipose tissue (sWAT) using QIAzol Lysis Reagent (Qiagen). The extracted RNAs 189 
were treated with DNase (Qiagen, Ireland). Complementary DNA was synthetized from 600ng total 190 
RNA using SuperscriptTM II Reverse Transcriptase kit (Life Technologies, Ireland), and subjected 191 
to Real-Time PCR (Roche, Ireland) using SYBR Green Select Master Mix (Roche, UK) as detailed 192 
before
(40)
. The gene expression was calculated using 2-ΔΔCp and normalised against the reference 193 
gene β-actin (intestine and adipose tissue) and YWAZ (hypothalamus). The sequence of the primers 194 
can be found elsewhere
(25; 30; 40)
. 195 
 196 
Plasma leptin, glucose and triglyceride levels 197 
Plasma leptin and glucose levels were determined using Mouse Leptin ELISA kit (Crystal Chem, 198 
USA) and Mouse Glucose Assay (Crystal Chem, USA) respectively. Triglyceride (TAG) level in 199 
the plasma was measured using Triglyceride Quantification Assay Kit (abcam, UK). 200 
 201 
Statistical analysis 202 
For power calculation, the coefficient of variation was measured using data (body weight gain) 203 
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from a previous study
(40)
 and determined to be 8.8%. For a power of 80% and a significance level of 204 
5%, this allows detection of a difference of 14% with a sample size of 8 mice per treatment. Body 205 
weight and energy intake differences over 10 weeks were analysed by a two-way repeated-measures 206 
ANOVA with Bonferroni’s post hoc pairwise comparisons. Statistical analysis of gene expression, 207 
cumulative energy intake, intestine weight/intestine length, plasma leptin and triacylglycerol data 208 
were performed using one-way ANOVA followed by pairwise comparison using Bonferroni’s post 209 
hoc test. Non-parametric data were compared by Kruskal-Wallis ANOVA followed by Mann-210 
Whitney U test. Data were expressed as mean ± SEM and significance was set at P<0.05 using 211 
SPSS software version 24 (IBM Corp). VO2 and heat production was analysed by ANCOVA (SAS 212 
software version 9.3), with total body weight being used as the covariant. 213 
Gut microbiota data were statistically analyzed by Adonis and Anosim for beta-diversity analysis. 214 
ANOVA was used to calculate significance for alpha-diversity-related analyses (statistical 215 
significance established at P<0.05). Statistical differences across multiple samples were determined 216 
by Kruskal-Wallis and False discovery rate (FDR, qvalue) control based on the Benjamini-217 
Hochberg procedure, used to correct for multiple testing with the R statistical package 218 
(https://www.r-project.org/). Test for association across all groups of samples were performed 219 
through correlation analysis. This was based on Spearman’s rank correlation test by the R function 220 
of cor.test, which aimed to examine similar expression association profiles between groups of 221 
samples (https://www.r-project.org/package=corrplot) and adjustment of the Pvalue by the 222 
Benjamini-Hochberg method. Statistical significance was established at P<0.05 (*), with other 223 
ranges, i.e. P<0.01 (**) and P<0.001 (***), also being noted.  224 
Results 225 
LAB increased cumulative energy intake but not weight gain  226 
Mice fed HFD-LAB and HFD-CAS had similar body trajectories (Fig. 1A) but differed from the 227 
LFD-CAS group in the time taken to increase weight. Notably, the HFD-CAS group had a 228 
significantly higher weight than LFD-CAS by week 3 (P=0.033) while the weight of the HFD-LAB 229 
group did not significantly exceed that of the LFD-CAS group until week 6 (P=0.045) 230 
(F(8,160)=440.2, P<0.001 for the effect of the Time, F(2,20)=5.5, P<0.05 for the effect of the Diet, 231 
F(16,160)=11.6, P<0.001 for the effect of the Time x Diet interaction) (Fig. 1A). Despite having 232 
similar body weight trajectories, the energy intake of HFD-LAB showed a trend towards an 233 
increase at week 2 (P=0.053) (413±9 kJ in HFD-LAB, 383±8 kJ in HFD-CAS and 293± 8 kJ in 234 
LFD-CAS) and it was higher in HFD-LAB compared to HFD-CAS at week 4 (P=0.037) 235 
(F(7,140)=7.2, P<0.001 for the effect of the Time, F(2,20)=81.7 , P<0.001 for the effect of the Diet, 236 
F(14,140)=1.3 , P>0.05 for the effect of the Time x Diet interaction) (Fig. 1B). The cumulative energy 237 
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intake of HFD-LAB was significantly increased by week 10 relative to HFD-CAS (P=0.043) (Fig. 238 
1C). The difference in energy intake was reflected in the hypothalamic expression of neuropeptides. 239 
Notably, at week 10, the expression of the anorexigenic neuropeptide pomc was reduced relative to 240 
the LFD-CAS control (P=0.043 compared to HFD-CAS and P=0.001 compared to HFD-LAB), 241 
without showing significant difference between the two HFD groups. (Fig. 1D). While the gene 242 
expression for the orexigenic neuropeptides ghrelin and npy remained unchanged, the gene 243 
expression of growth hormone secretagogue receptor (ghsr) was reduced in both HFD groups 244 
compared to LFD-CAS (P=0.012 relative to HFD-CAS and P=0.001 relative to HFD-LAB) (Fig. 245 
1D). Similar to pomc expression, the expression of ghsr between HFD-CAS and HFD-LAB groups 246 
did not change. There was no effect due to diet on the expression of the fatty acid synthase (fasn). 247 
The mismatch between energy intake and weight gain was unrelated to energy expenditure as both 248 
HFD-CAS and HFD-LAB groups had similar 24h VO2 levels (97 ±3 in HFD-LAB, 95±3 in HFD-249 
CAS and 101±3 in LFD-CAS; all values in ml/hr) and heat production (2.1±0.05 in HFD-LAB, 250 
2.0±0.05 in HFD-CAS and 2.2±0.06 in LFD-CAS; all values in kJ/hr), where both parameters were 251 
measured during week 8 and 9 period. There were no differences between groups in terms of 24h 252 
locomotor activity (303±28 in HFD-LAB, 293±29 in HFD-CAS and 365±37 in LFD-CAS). While 253 
the HFD-CAS and the HFD-LAB groups had similar RER, the corresponding values were lower 254 
compared to LFD-CAS (both with P<0.001), consistent with increased fat consumption by former 255 
groups (0.816±0.014 in HFD-LAB and 0.809±0.014 in HFD-CAS versus 0.916±0.008 LFD-CAS). 256 
 257 
LAB decreases the intestinal expression of glucose and fatty acid transporters 258 
To find an explanation for the apparent energy loss in the HFD-LAB group, the impact on gastro-259 
intestinal size and related gene expression of several nutrient transporters were measured. The 260 
intestinal length was unaffected by the diet (33.2±0.61cm in HFD-LAB, 32.4±0.74 cm in HFD-261 
CAS and 32.9±0.38 cm in LFD-CAS). While the intestinal weight expressed relative to the length 262 
and body weight was similar between HFD-CAS and HFD-LAB groups, this was significantly 263 
lower compared to LFD-CAS controls (P=0.039 relative to HFD-CAS and P=0.019 relative to 264 
HFD-LAB) (Fig. 2A). The data from ANCOVA analysis showed that there was not significant 265 
effect of diet on intestinal weight/length when body weight was used as a covariant (0.024±0.001g 266 
in HFD-LAB, 0.025±0.001g in HFD-CAS and 0.026±0.001g in LFD-CAS).  267 
In the ileum, we observed a significant decrease in the expression of the sodium-glucose transporter 268 
protein (slgt1) in both high fat groups compared to the LFD-CAS (P=0.026 relative to HFD-CAS 269 
and P=0.029 relative to HFD-LAB), but glut2 gene expression was specifically reduced in the 270 
HFD-LAB compared to LFD-CAS (P=0.01) and it showed a trend towards a decrease, at the 271 
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significance threshold, compared to HFD-CAS (P=0.053) (Fig. 2B). While fatp4 gene expression 272 
was unaffected in the ileum, the cluster of differentiation 36 (cd36; an integral membrane protein 273 
responsible for importing fatty acids into the cell) was reduced in the HFD-LAB compared to the 274 
LFD-CAS (P=0.001) and HFD-CAS (P<0.001) (Fig. 2B). The expression of genes encoding the L-275 
amino acid transporter, lat4, and the neutral amino acid transporter slc6a19 was not significantly 276 
affected (Fig. 2B). 277 
The same gene expression was measured in the jejunum. Similar to the ileum data, cd36 gene 278 
expression in the jejunum was reduced in the HFD-LAB group compared to the other two groups 279 
(P=0.001 relative to LFD-CAS and P<0.001 relative to HFD-CAS), whereas glut2 expression did 280 
not change across the groups (Fig. 2C). In addition, in the jejunum, the level of expression of fatp4 281 
was significantly higher in the HFD-LAB group compared to the LFD-CAS control group 282 
(P<0.001) and the expression of lat4 showed a trend towards an increase in the HFD-LAB fed mice 283 
relative to HFD-CAS fed mice (P=0.061) (Fig. 2C). 284 
In light of the results obtained for glut2 and cd36 gene expression, we measured the levels of 285 
glucose and triglyceride in the plasma. We observed that the glucose in the plasma of HFD-LAB 286 
fed mice (311±23 mg/dL) was not significantly different to HFD-CAS (293±8 mg/dL) but was 287 
lower compared to LFD-CAS fed mice (364±8 mg/dL, P=0.018). The level of triglyceride in the 288 
HFD-LAB (37±4 mg/dL), HFD-CAS (35±6 mg/dL) and LFD-CAS (36±5 mg/dL) groups was not 289 
significantly different. 290 
 291 
LAB does not affect leptin gene expression and plasma hormone availability  292 
Several tissues were harvested from the mice and their weights were recorded (Fig. 3A). The 293 
weights of both the subcutaneous adipose tissue (sWAT) and the eWAT were greater in both the 294 
HFD groups compared to the LFD-CAS control group (sWAT: P=0.002 relative to HFD-CAS and 295 
P=0.056 relative to HFD-LAB; eWAT: P=0.001 relative to HFD-CAS and P<0.001 relative to 296 
HFD-LAB) but there were no differences in the adipose tissues weights between HFD-CAS and 297 
HFD-LAB (Fig. 3A). Next, the expression of several genes involved in the catabolism and 298 
anabolism of fatty acids in the eWAT and sWAT was measured. In the current study, the expression 299 
in the eWAT of genes involved in fatty acid catabolism (carnitine palmoitoyltransferase I, cpt1; 300 
uncoupling protein, ucp; hormone-sensitive lipase, hsl; beta-3 adrenergic receptor β-3ar) and 301 
anabolism (acetylCoA carboxylase 1, acc1; fatty acid synthase, fasn; lipoprotein lipase, lpl) 302 
between HFD-LAB and HFD-CAS fed animals did not differ (Fig. 3B-C). There was also no 303 
change in the expression of genes involved in fatty acids transport, such as cd36, fatp1 and glut4 304 
(Fig. 3C). However, consistent with the increased adiposity of the high fat fed groups, acc1 gene 305 
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expression was down regulated in HFD-CAS (P=0.008) and HFD-LAB (P=0.002) compared to 306 
LFD-CAS (Fig. 3C). In addition, the inflammatory marker, cluster of differentiation 68 (cd68) 307 
expression showed a trend towards an increase in the HFD-CAS group compared to the LFD-CAS 308 
(P=0.057), but for the HFD-LAB group, the increase was not significant relative to LFD-CAS (Fig. 309 
3C). The unchanged adipose tissues weights, coupled with gene expression data in the eWAT, 310 
suggests an alternative mechanism of energy loss in the HFD-LAB group. We also measured leptin 311 
(ob) gene expression in the eWAT to assess if there is a specific effect of LAB in leptin regulation, 312 
similar to that attributed to the whey protein Lf
(26)
. 313 
Consistent with the gain in body weight and adipose tissue weight, the expression of the ob gene in 314 
the HFD-CAS group increased compared to the control LFD-CAS (P<0.001) and, in the HFD-LAB 315 
group, it showed a trend towards an increase relative to the LFD control (P=0.059), without 316 
showing any differences between the two HFD groups (P=0.08) (Fig. 3C). 317 
Similarly, no differences in ob expression were detected in the sWAT between the HFD groups 318 
(Fig. 3E), and the expression of fasn and glut4 genes were decreased compared with the LFD-CAS 319 
group (fasn: P=0.001 relative to HFD-CAS and P=0.001 relative to HFD-LAB; glut4: P=0.021 320 
relative to HFD-CAS and P=0.035 relative to HFD-LAB), with no difference between HFD-CAS 321 
and HFD-LAB groups (Fig. 3E). 322 
The ob gene expression in eWAT and sWAT was reflected in the plasma availability of leptin, as 323 
the presence of LAB in the HFD did not influenced the plasma hormone level, relative to HFD-324 
CAS (Fig. 3D).  325 
 326 
Beta-diversity and gut bacterial composition differs due to LAB intake. 327 
After quality filtration and length trimming an average of 182,494 high-quality 16S rRNA 328 
sequences per sample (i.e., faecal pellets collected from the colon) were obtained across two groups, 329 
i.e., HFD-CAS (n=8) and HFD-LAB (n=8). Analysis of this data revealed that, while alpha-330 
diversity did not differ significantly across groups, a significant difference in beta-diversity 331 
(P=0.002) between the microbiota of the HFD-CAS and HFD-LAB animals was apparent, as 332 
represented by distinct clustering upon Principal Coordinates Analysis (PCoA) of all 16S rRNA 333 
reads (clustered at 97% similarity) (Fig. 4A).  334 
Differences in beta-diversity were reflected by taxonomic differences between the HFD-CAS and 335 
HFD-LAB groups. At the phylum level, a lower Firmicutes/Bacteroidetes (ratio F/B) was apparent 336 
in the HFD-CAS samples (ratio F/B=1.23) relative to the HFD-LAB equivalents (ratio F/B=1.42), 337 
though significance was not achieved (Fig. 4B). At the family level, two families differed 338 
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significantly in a diet-associated manner. These were Lactobacillaceae (higher levels in HFD-LAB 339 
samples) and Streptococcaceae (higher proportions in HFD-CAS samples) (Table 1). 340 
At the genus level, statistically significant differences were apparent in the abundance of 341 
Parabacteroides, Bifidobacterium, Parvibacter and Lactobacillus, all of which were present in 342 
higher proportions in the HFD-LAB sample groups, as well as Lactococcus, Roseburia (P=0.021), 343 
Phascolarctobacterium (P=0.018) and Turicibacter, present in higher proportions in the HFD-CAS 344 
group (Table 1), were noted. 345 
To assess the possibility that the presence of particular taxa within the chow containing CAS could 346 
be responsible for the associated increased proportion of Streptococcaeae in the gut, analysis of the 347 
microbiota of the CAS-containing chow was performed. This revealed that the family 348 
Streptococcaceae (99.6% and 99.8% in LFD-CAS and HFD-CAS chow, respectively) and the 349 
associated genus, Lactococcus (99.6% and 99.8% in LFD-CAS and HFD-CAS chow, respectively), 350 
were dominant (Table S2). 351 
Correlation and independent analyses of expression association profiles were conducted between 352 
cd36 and glut2 expression levels, as well as energy intake, against bacterial composition at the 353 
genus level. Dairy taxa potentially sourced from the food substrate were not considered. After 354 
adjustment for multiple testing (BH-corrected), it was noted that energy intake positively correlated 355 
within the group of HFD-CAS samples with Parabacteroides. Within the HFD-LAB group, 356 
Parabacteroides negatively correlated with cd36 expression. Glut2 expression was positively 357 
correlated with Parabacteroides in HFD-LAB samples (Fig. 4C).  358 
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Discussion 359 
In this study, we investigated the effects of a specific dietary whey protein (LAB) on intestinal-360 
adipose-hypothalamic control of energy balance. We show that supplementation of LAB in a HFD 361 
reduced cd36 and glut2 gene expression in the intestine and was associated with changes in the 362 
composition of the gut microbiota. These changes were accompanied by increased cumulative 363 
energy ingestion. This, coupled with the fact that targeted deletion of the glut2 gene increases 364 
energy intake
(8)
, suggests a potential link between gut microbiota, intestinal nutrient transporters 365 
and energy intake in response to LAB supplementation. These effects were unrelated to adiposity, 366 
as HFD-LAB fed mice had similar weight gain, adipose tissue weight (both eWAT and sWAT) and 367 
plasma TAG.   368 
 369 
Previous studies have shown that diets rich in whey proteins cause short-term satiety effects in mice 370 
and in humans
(41; 42; 43)
. Long term effects on energy balance, however, do not involve the 371 
production of satiety hormones
(19)
. On a background of HFD intake, which has been shown to 372 
reduce the brain sensitivity to satiety hormones
(44)
, the increased energy intake in mice fed with 373 
HFD-CAS compared to LFD and even higher (cumulative) energy intake in HFD-LAB is likely to 374 
involve another mechanism of regulation within the adipose tissue-gut-brain connection. 375 
 376 
Hypothalamic neuropeptide expression provided an insight into the regulatory effect of LAB on 377 
energy intake. Notably, the expression of the anorexigenic neuropeptide pomc gene expression was 378 
significantly lower in the HFD-CAS group in line with the higher energy intake compared to LFD-379 
CAS, similar to that shown in previous studies
(26; 30)
. In the HFD-LAB group, while pomc 380 
expression remained low, the expression of the orexigenic neuropeptide, npy, did not change across 381 
the groups. In contrast, effects on energy intake and on hypothalamic pomc and npy expression 382 
were previously found in mice fed with WPI compared to casein in a LFD
(22)
. In addition, neither 383 
the expression of npy nor the cumulative energy intake changed in mice fed a HFD containing 384 
lactoferrin compared to casein
(26)
. These data suggest that the whey protein LAB have bioactivity 385 
that influences energy intake and that is not mediated by the modulation of hypothalamic 386 
neuropeptide genes investigated in this study. 387 
In the current study, while the HFD-CAS group increased weight rapidly, reaching a significant 388 
increase relative to LFD values by week 3, it was a further 3 weeks before the mice fed HFD-LAB 389 
diet significantly increased body weight relative to LFD fed animals. The finding that the higher 390 
cumulative energy intake was not reflected in the increased body weight in the HFD-LAB group 391 
suggests a mechanism must exist to explain the missing energy from the supply. This is consistent 392 
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with a rat study, which showed that HFD intake with LAB did not change energy intake but 393 
decreased adiposity
(27)
. The difference in energy intake between this study and our current study 394 
could be related to the fact that the rat study included both egg albumin and LAB as the protein 395 
sources in the same diet, whereas we used LAB as the only protein source. This apparent energy 396 
loss could be related to lipid oxidation, as a recent study showed that pre-exercise LAB-enriched 397 
whey protein meal preserved lipid oxidation alongside rapid delivery of amino acids to tissues for 398 
use during exercise, decreasing the adiposity in rats
(45)
. However, we did not observe this effect in 399 
the sedentary mice used in our current study, as RER was similar between HFD-LAB and HFD-400 
CAS fed mice and adipose-specific gene expression linked to lipid catabolism also did not change. 401 
This, coupled with the similar sWAT and eWAT weights between HFD-LAB and HFD-CAS 402 
groups, suggests that the energy loss in the sedentary mice fed LAB occurs through another 403 
mechanism. 404 
 405 
It has been shown previously that WPI reduces fat absorption in humans and mice
(29; 46; 47)
, and we 406 
showed that this effect could be related to decreased ileal fatp4 gene expression
(22)
. In addition, we 407 
also showed a time course reduction of glut2 gene expression in the same region with 17 weeks of 408 
WPI intake and this effect on intestinal gene expression was independent of sucrose content in the 409 
diet
(22)
. In the present study, by feeding a constituent protein of WPI, i.e. LAB, to mice for a shorter 410 
time period (10 weeks) and by analysing their intestinal gene expression, we now observed a 411 
reduction in the expression of sglt in both HFD groups relative to LFD groups. This can be a 412 
reflection of higher carbohydrate content in the LFD compared to the two HFDs (Table S1). In 413 
addition, we show a reduction of glut2 expression in the ileum exposed to HFD, specifically with 414 
LAB. The similar effects of LAB and WPI on intestinal glut2 expression in the ileum suggests that 415 
LAB may contributes to the bioactivity in WPI influencing glut2 expression and this bioactivity, 416 
whatever it may be, appears to be effective independent of sucrose or fat content in the diet
(22)
. It 417 
was shown that the recruitment of apical GLUT2 in the small intestine is detrimental for health, i.e., 418 
it leads to an excess of glucose uptake with increased obesity and type 2 diabetes risk
(48)
. Our study 419 
suggests a potential effect of a diet enriched in LAB in the control of intestinal glucose transporter-420 
related transcripts, that could influence glucose absorption. In another in vitro study, using human 421 
intestinal Caco-2 cells, it was shown that polyphenols can also lead to a decrease in the abundance 422 
of apical GLUT2
(49)
.  423 
 424 
In the current study, we observed also a reduction in cd36 gene expression within both ileum and 425 
jejunum. Thus, in combination, these data further support the hypothesis the whey protein LAB 426 
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seems to affect different components of the mechanism involved in the absorption of glucose and 427 
fatty acids within the small intestine, at least at the gene expression level. This would explain, at 428 
least in part, the loss of energy that occurs in mice fed LAB. Further analysis aimed to look at the 429 
protein level and energy content in the faeces need to be done to confirm this hypothesis. Notably, 430 
differences in the level of cd36 and glut2 in the jejunum during LAB intake are in agreement with 431 
the fact that the modality and the degree of absorption can change along the intestinal tract. This is 432 
due to a different density of nutrient transporters across the three major regions of the small 433 
intestine
(50)
. Based on the effect of LAB in a HFD on expression of nutrient transporters in the 434 
intestinal epithelium and associated energy loss, we speculate that mice compensate by increasing 435 
energy intake. In fact, in this study we observed that the levels of glucose and triacylglycerol in the 436 
plasma did not show significant changes between HFD groups. 437 
 438 
Furthermore, the HFD groups consumed more energy than LFD. Since there were no differences in 439 
the energy expenditure, the energy surplus has been stored in the adipose tissue. Thus, the lower 440 
expression of acc and fasn in the adipose tissue, presumably reflects the reduced necessity to 441 
produce fat endogenously when there is an external supply of excess energy. A similar reduction in 442 
fasn gene expression has been noted in a previous study from our group
(21)
. On the contrary, other 443 
studies show that HFD intake increases fasn and acc in the adipose tissue
(51; 52; 53)
. The reasons for 444 
these discrepancies are unclear, but we speculate that contributing factors can include different 445 
genetic background, age, diet (composition and duration) and different housing environment. 446 
 447 
Leptin, a hormone encoded by the ob gene, controls food intake and body weight through an 448 
interaction with specific receptors within the hypothalamus
(54)
. In obese humans and in mice fed an 449 
obesogenic diet the adipose tissue mass increases, enhancing significantly the level of serum leptin 450 
and leading to metabolic dysfunctions
(55)
. In addition to the effect on intestinal nutrient transporters 451 
and energy intake, WPI in a LFD also reduced eWAT weight and plasma leptin, raising the 452 
possibility that the reduced adipose tissue and associated signals, including reduced leptin, could 453 
have stimulated the energy intake in mice. However, feeding mice with a HFD containing 20% of 454 
WPI for 8 weeks did not have an effect on plasma leptin levels, compared to mice fed a HFD 455 
containing CAS
(30)
. On the contrary, HFD containing lactoferrin significantly reduced plasma leptin 456 
levels compared to the HFD-CAS controls
(26)
. This is another demonstration of the distinct 457 
bioactivities that WPI-associated whey proteins can have. In this study, mice fed a HFD containing 458 
LAB as the sole protein source showed no significant decrease in plasma leptin, which was 459 
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reflected in no change in eWAT and sWAT ob gene expression in the HFD-LAB group, compared 460 
to the HFD-CAS group. 461 
 462 
We also demonstrated that a HFD containing LAB has a strong influence on the composition of the 463 
gut microbiota. Beta-diversity data highlighted differences in the clustering of samples from the 464 
HFD-LAB group compared to the HFD-CAS group. Corresponding taxonomic analyses were also 465 
completed. In particular, we observed a significantly higher proportion of Parabacteroides in the 466 
HFD-LAB group, which is notable in that this genus showed a significantly positive correlation 467 
with the expression of nutrient transporters. Notably other studies have suggested that 468 
Parabacteroides protects the gut from inflammation and there have been reports of the apparent 469 
absence of this genus in the digestive tract of people affected by Inflammatory Bowel Diseases
(56; 470 
57)
. We also observed that the genera Bifidobacterium and Lactobacillus are significantly more 471 
abundant in the HFD-LAB group. In several human studies, an association between lower levels of 472 
Bifidobacterium and obesity was noted
(58; 59; 60)
. In addition, higher levels of Bifidobacterium have 473 
been linked with an increase in SCFA production, an improvement of gut mucosal barrier and lower 474 
intestinal LPS levels
(60; 61)
. Furthermore, specific strains of Bifidobacterium and Lactobacillus spp. 475 
have been shown to exhibit anti-obesity effects
(62)
. It is worth highlighting the importance of species 476 
and strain level differences as, for example, human and animal studies have highlighted an 477 
association between different Lactobacillus species with weight gain or weight protection
(63; 64)
. For 478 
this reason, more accurate in-depth metagenomic analyses, such as shotgun analysis, should be 479 
considered in the future to investigate the Lactobacillus species that populate the gut of HFD-LAB 480 
fed mice.  481 
A number of bacterial taxa typically associated with dairy products were also found to be altered in 482 
the gut. A recent human feeding study demonstrated that many bacteriophages and Streptococcus 483 
and Lactococcus genera, that were significantly altered in individuals whose diet was supplemented 484 
with whey proteins, were present in high proportions within the whey protein supplement
(65)
, and 485 
thus presumably originated from the food source. The family Streptococcaceae and the associated 486 
genus, Lactococcus, are significantly more abundant in the HFD-CAS group compared to the HFD-487 
LAB group. This is consistent with our previous study that showed that Streptococcaceae 488 
proportion increased significantly in the CAS-fed mice compared to WPI-fed mice
(22)
. However, 489 
this phenomenon is likely a reflection of the high proportion of Streptococcaceae and Lactococcus 490 
reads detected after analysis of both LFD-CAS and HFD-CAS chows.  491 
The changes in the gut microbiota in the presence of LAB, coupled with the reduced intestinal 492 
expression of genes for nutrient transporters, support and provide a potential scenario for the energy 493 
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mismatch in the HFD-LAB group compared to the control group. However, the specific mechanism 494 
that connects these changes in intestinal transporters gene expression, gut microbiota and energy 495 
intake in the presence of LAB remains to be elucidated. Further studies are needed to assess if these 496 
effects are seen with different genetic background, sex, housing environment (group versus single 497 
housing) and dietary fat content and duration. In conclusion, this present study has demonstrated for 498 
what is to our knowledge the first time, how a HFD containing a specific whey protein, i.e. LAB, 499 
specifically affects the metabolism, microbiota and nutrient absorption regulation, without 500 
preventing weight gain and adipose tissue mass accumulation in mice. 501 
 502 
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 527 
 528 
 529 
 530 
 531 
 532 
 533 
 534 
Table 1 535 
 536 
 537 
 538 
 539 
 540 
 541 
 542 
 543 
 544 
 545 
 546 
 547 
Table 1: Relative abundance (%) of genera and families in which their abundance is significantly 548 
higher either in the HFD-CAS group or in the HFD-LAB group. Statistical differences across 549 
multiple samples were estimated by the bioinformatics methods “False discovery rate” control 550 
based on the “Benjamini-Hochberg” procedure 551 
 552 
 553 
 554 
 555 
Family 
HFD-LAB vs HFD-
CAS 
Relative Abundance 
Streptococcaceae P=0.029 ↑ HFD-CAS 0.082895775 
Lactobacillaceae P=0.015 ↑ HFD-LAB 1.18133309 
Genus     
Lactococcus P=0.001 ↑ HFD-CAS 0.077810661 
       Turicibacter        P=0.024 ↑ HFD-CAS                0.301261529 
Streptococcus P=0.001 ↑ HFD-LAB 0.148479572 
Parvibacter P=0.039 ↑ HFD-LAB 0.012092907 
Lactobacillus P=0.011 ↑ HFD-LAB 1.180503082 
Parabacteroides P=0.026 ↑ HFD-LAB 0.045986668 
Bifidobacterium P=0.05 ↑ HFD-LAB 0.159330093 
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